Successful allogeneic bone marrow transplantation (BMT) by injection of bone marrow cells via portal vein: Stromal cells as BMT-facilitating cells

Stem Cells

Volumn 19, Issue 2, 2001, Pages 144-150

  Fan, Tian Xue ^a   Hisha, Hiroko ^a   Jin, Tie Nan ^a   Yu, Cheng Ze ^a   Lian, Zhe Xiong ^a   Guo, Shu Bin ^a   Cui, Yun Ze ^a   Feng, Biao ^a   Yang, Guo Xiang ^a   Li, Qing ^a   Ikehara, Susumu ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Bone marrow stromal cells; Bone marrow transplantation; Hemopoietic stem cells; Portal vein

Indexed keywords

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL INTERACTION; CELL MIGRATION; COLONY FORMING UNIT S; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HISTOLOGY; LIVER; MOUSE; NONHUMAN; PORTAL VEIN; SPLEEN; STROMA CELL;

ANIMALIA;

EID: 0035106669     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.19-2-144     Document Type: Article

References (27)

1. Human marrow transplantation: An immunological perspective
2. Marrow transplantation from unrelated donors for treatment of hematologic malignancies: Effect of mismatching for one HLA locus
3. Bone marrow transplantation for autoimmune diseases
4. Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation
5. Immunity and tolerance are related, and governed by antigen migration and localization
6. Bone marrow chimerism and transplantation tolerance
7. Successful bone marrow transplantation by bone grafts in chimeric-resistant combination
8. Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation
9. Major histocompatibility complex restriction between hematopoietic stem cells and stromal cells in vivo
10. Requirement of major histocompatibility complex-compatible microenvironment for spleen colony formation (CFU-S on day 12 but not on day 8)
11. Major histocompatibility complex restriction between hematopoietic stem cells and stromal cells in vitro
12. Studies on the induction of tolerance to alloantigens. I. The abrogation of potential delayed-type-hypersensitivity responses to alloantigens by portal venous inoculation with allogeneic cells
13. Hepatic suppression of sensitization to antigen absorbed into the portal system
14. Fate of allogeneic or syngeneic cells in intravenous or portal vein injection: Possible explanation by portal vein injection
15. A strategy for organ allografts without using immunosuppressants or irradiation
16. Induction of donor-specific T cell anergy by portal venous injection of allogeneic cells
17. Conditions controlling the proliferation of hemopoietic stem cells in vitro
18. Monoclonal antibodies against a preadipose cell line (MC3T3-G2/PA6) which can support hemopoiesis
19. Production of hemopoietic stem cell-chemotactic factor by bone marrow stromal cells
20. Induction of recombination activating gene expression in a human lymphoid progenitor cell line: Requirement of two separate signals from stromal cells and cytokines
21. Evidence for migration of donor bone marrow stromal cells into recipient thymus after bone marrow transplantation plus bone grafts; a role of stromal cells in positive selection
22. A novel migration pathway for rat dendritic cells from the blood: Hepatic sinusoids-lymph translocation
23. - αβ T cells of mice immunized with allogeneic cells via the portal vein in vitro
24. Specific manipulation in vivo of immunity to skin grafts bearing multiple minor histocompatibility differences
25. Impact of perioperative portal venous administration of donor lymphocytes on survival of rat cardiac allografts and renal grafts of the mongrel dog
26. Studies on the induction of tolerance to alloantigens. II. The generation of serum factor(s) able to transfer alloantigen-specific tolerance for delayed-type hypersensitivity by portal venous inoculation with allogeneic cells
27. Persistent tolerance induced after portal venous injection of allogeneic cells plus cyclophosphamide treatment